Invention Grant
- Patent Title: Methods of producing hybrid antibodies
-
Application No.: US14036530Application Date: 2013-09-25
-
Publication No.: US09382567B2Publication Date: 2016-07-05
- Inventor: Andrew J. Murphy , George D. Yancopoulos , Margaret Karow , Lynn Macdonald , Sean Stevens , Aris N. Economides , David M. Valenzuela
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Foley Hoag LLP
- Agent Brendan T. Jones; Neil Miyamoto
- Main IPC: C12P21/00
- IPC: C12P21/00 ; C07K16/00 ; A01K67/027 ; C12N15/90 ; C12N15/67 ; C07K16/46 ; C12N15/85 ; C07K16/28

Abstract:
A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.
Public/Granted literature
- US20140017229A1 Methods of Modifying Eukaryotic Cells Public/Granted day:2014-01-16
Information query